Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma

Front Pharmacol. 2024 Jan 11:14:1354581. doi: 10.3389/fphar.2023.1354581. eCollection 2023.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1124214.].

Keywords: EDP; EET; cytochrome P450; hepatocellular carcinoma; lipidomics; omega-3 fatty acids; oxylipins; sorafenib.

Publication types

  • Published Erratum